These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-001616-45 ESTUDIO PILOTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL RECAMBIO PLASMÁTICO CON ALBÚMINA HUMANA 5% EN EL ACLARAMIENTO PERIFÉRICO DEL PEPTIDO BETA-AMILOIDE, Y SUS EFECTOS EN PACIENTES CON ENFERMEDAD DE... bad-data
Ongoing 2005-004830-42 "Ensayo clínico piloto, unicéntrico, controlado con placebo, a doble-ciego, aleatorio y cruzado con alfa-1-antitripsina humana en sujetos con fibromialgia". not-yet-due
Completed, report not yet due 2006-002635-24 A STUDY OF IMMUNOLOGIC SAFETY FOR ALPHANATEŇ IN PREVIOUSLY TREATED PATIENTS DIAGNOSED WITH SEVERE HEMOPHILIA A 2018-12-14 not-yet-due
Reported results 2007-000414-36 ESTUDIO FASE II PARA VALORAR LA EFICACIA Y SEGURIDAD DEL RECAMBIO PLASMÁTICO CON ALBÚMINA 5% EN EL ACLARAMIENTO DEL PÉPTIDO BETA-AMILOIDE EN LÍQUIDO CEFALORRAQUÍDEO, Y SUS EFECTOS EN PACIENTES CON ENF... 2011-03-07 due-trials
Reported results 2008-000072-25 A Prospective, Single-blind, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis during Peripheral Vascular Surgery 2014-05-05 due-trials
Completed, but no date 2008-002037-67 EFFICACY AND SAFETY OF FACTOR IX (FIX) CONTAINED IN ALPHANINE® AND ITS PHARMACOKINETIC COMPARISON WITH BENEFIX® IN PATIENTS WITH SEVERE HEREDITARY HAEMOPHILIA B (Follow-up study of the trial IG404: E... bad-data
Completed, but no date 2008-003920-40 ESTUDIO CLÍNICO SOBRE LOS EFECTOS DE LA ADMINISTRACIÓN PROLONGADA DE ALBUMINA 20% SOBRE LA FUNCIÓN CARDIOCIRCULATORIA Y RENAL, Y LA HEMODINAMICA HEPATICA EN PACIENTES CON CIRROSIS AVANZADA Y ASCITIS bad-data
Completed, but no date, and reported results 2008-007313-68 A Prospective Randomized Pilot study to evaluate the effect of preoperative antithrombin supplementation on postoperative levels of antithrombin in patients undergoing cardiac surgery with cardiopulmo... bad-data
Ongoing 2009-009918-40 Ensayo Clínico fase IV, prospectivo, aleatorizado, doble ciego, de grupos paralelos y unicéntrico, para evaluar el efecto de la taurina en Nutrición Parenteral Total sobre la función hepática en pacie... not-yet-due
Exempt, with results 2009-012086-66 A Phase 1/2a, Open Label, Dose Escalation, Safety Study of Intra-thrombus Plasmin (Human) Administration in Acute, Middle Cerebral Artery, Ischemic Stroke 2014-02-10 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-019760-36 A Phase 2, Randomized, Open-label (with Blinded Plasminogen Activator and Placebo Control Groups) Study to Evaluate the Effects of Different Intra-thrombus Infusion Regimens of Plasmin (Human) Compare... 2014-09-03 bad-data
Completed, but no date, and reported results 2010-020931-37 EFFICACY AND SAFETY OF NIULIVA FOR THE PREVENTION OF HEPATITIS B VIRUS RECURRENCE IN NEWLY ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS bad-data
Ongoing 2010-021360-15 "EFECTOS DEL RECAMBIO PLASMÁTICO SOBRE LA CAPACIDAD FUNCIONAL DE LA ALBÚMINA SÉRICA, LA DISFUNCIÓN CIRCULATORIA, LA FUNCION RENAL Y CEREBRAL EN PACIENTES CIRRÓTICOS CON “ACUTE-ON-CHRONIC LIVER FAILURE... not-yet-due
Not reported 2011-001598-25 A multicenter, randomized, controlled study to evaluate the efficacy and safety of short-term plasma exchange followed by long-term plasmaphereses with infusion of human albumin combined with intraven... 2018-03-06 due-trials
Ongoing 2012-003450-92 EVALUATION OF THE PHARMACOKINETIC PROFILE, CLINICAL EFFICACY AND SAFETY OF THE VON WILLEBRAND FACTOR CONTAINED IN FANHDI® (DOUBLE-INACTIVATED HUMAN ANTI-HEMOPHILIC FACTOR) IN PEDIATRIC PATIENTS WITH V... not-yet-due
Listed as ongoing, but also has a completion date 2013-001870-38 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alphal-Proteinase Inhibitor (Human) in Subjec... 2017-04-04 bad-data
Exempt 2013-004343-23 Studio per indagare le proprietà farmacocinetiche (per vedere quanto è attivo il farmaco di studio nel sangue e quanto tempo ci vuole per il farmaco di studio per uscire dal sangue), l'efficacia e la ... not-yet-due
Ongoing 2013-004503-39 A multicenter, prospective, randomized, placebo-controlled, double-blind, parallel-group clinical trial to assess the efficacy and safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in p... not-yet-due
Completed, but no date, and reported results 2013-004842-40 Pilot study to evaluate the effect of plasma exchange in motor and cognitive function in patients with amyotrophic lateral sclerosis bad-data
Listed as ongoing, but also has a completion date and reported results 2013-005098-28 A multicenter, prospective, open-label, non-controlled clinical trial to assess the efficacy and safety of Immune Globuline (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in patients with Mya... 2018-04-17 bad-data
Completed, report not yet due 2013-005099-17 A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/ chromatography Purified (lGIV -C) as a Corticosteroid S... 2019-02-14 not-yet-due
Reported results 2013-005127-16 A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis during Peripheral Vascular Surgery 2015-12-02 due-trials
Reported results 2013-005128-40 A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Parenchymous Tissue Open Surgerie... 2015-12-28 due-trials
Reported results 2013-005159-34 A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Soft Tissue Open Surgeries 2015-06-04 due-trials
Completed, but no date Terminated 2014-002007-13 A multicenter, randomized, placebo-controlled, double-blind and crossover pilot trial with human alpha-1 antitrypsin in patients with chronic fatigue syndrome bad-data
Reported results 2014-003997-18 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/ Chromatography Purified (IGIV -C) in Symptomatic Subje... 2018-01-26 due-trials
Listed as ongoing, but also has a completion date 2015-003290-15 A Multi-Centre, Open-Label, Single Arm Trial to Evaluate Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency 2019-05-15 bad-data
Ongoing 2015-004110-23 An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified not-yet-due
Ongoing 2015-005524-26 A Multicenter Phase 2 Open-Label, Single-Arm, Prospective, Interventional Study of Plasma-Derived Factor VIIIIVWF Alphanate® in Immune Tolerance Induction Therapy in Subjects with Congenital Hemophili... not-yet-due
Ongoing 2016-001787-10 Effects of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects with "Acute-On-Chronic Liver Failure" (ACLF) at High Risk of Hospital not-yet-due
Ongoing 2016-001789-28 Prevention of Mortality with Long-Term Administration of Human Albumin in Subjects with Decompensated Cirrhosis and Ascites not-yet-due
Other 2016-004489-24 A Prospective, Randomised, Active-Controlled, Single-blind, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Haemostasis during... not-yet-due